abstract |
The present invention relates to a therapeutic agent for chronic kidney disease containing a substance that suppresses NNMT enzyme activity or a substance that suppresses NNMT gene expression, and a therapeutic agent for chronic kidney disease that targets an NNMT enzyme or NNMT gene. The present invention relates to a screening method. |